NCT06516562招募中不适用
Demographic, Clinical, Biological, Treatment Characteristics and Cardiovascular Events of Patients With Heart Failure in Vietnam: a Multicenter Prospective Observational Study
University Medical Center Ho Chi Minh City (UMC)1 个研究点 分布在 1 个国家目标入组 2,500 人开始时间: 2023年8月1日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 2,500
- 试验地点
- 1
- 主要终点
- Heart failure rehospitalization
研究概览
简要总结
Describe the clinical characteristics, paraclinical features, and treatment during hospitalization, as well as at 1, 3, and 12 months post-discharge, of heart failure patients at selected cardiovascular centers in Vietnam.
详细描述
Study Design: Prospective cohort study
Study Subjects: Patients discharged with a diagnosis of heart failure with reduced or mildly reduced ejection fraction.
Inclusion Criteria:
- Patients aged 18 years and older
- Diagnosed with heart failure at the time of discharge
- Have an ejection fraction (based on imaging modalities such as echocardiography or cardiac MRI) recorded closest to the time of discharge, showing a left ventricular ejection fraction of less than 50%
Exclusion Criteria:
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients aged 18 years and older
- •Diagnosed with heart failure at the time of discharge
- •Have an ejection fraction (based on imaging modalities such as echocardiography or cardiac MRI) recorded closest to the time of discharge, showing a left ventricular ejection fraction of less than 50%
排除标准
- •Patients and their relatives do not have means of communication with healthcare staff (phone, computer, messaging, etc.)
- •Patients do not reside in Vietnam after discharge
研究组 & 干预措施
Heart failure with reduced or mildly reduced ejection fraction
干预措施: Optimal treatment (Drug)
结局指标
主要结局
Heart failure rehospitalization
时间窗: 12 months
Patient rehospitalization due to cardiovascular causes, excluding apparent non-cardiac causes.
All-cause mortality
时间窗: 12 months
Death from any cause
次要结局
- Guideline-directed medical therapy detail(12 months)
- Major adverse cardiovascular events(12 months)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Demographics, Clinical and Paraclinical Characteristics of Multiple Sclerosis in EgyptMultiple SclerosisNCT02970370Cairo University2,752
已完成
不适用
Myocardial Infarction With Non-obstructive Coronary Arteries in Turkish PopulationAtrial FibrillationDiabetes MellitusMyocardial InfarctionAcute Coronary SyndromeNCT03364387Cardiovascular Academy Society, Turkey16,026
Unknown
不适用
Clinical Pulmonary EmbolismAcute Pulmonary EmbolismNCT05469724Assiut University100
已完成
不适用
Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HR+/HER2- Advanced/Metastatic Breast Cancer In Real World Settings.Breast Cancer MetastaticNCT05155566Pfizer847
尚未招募
不适用
Evaluation of Clinical and Pathological Characteristics and Routine Treatment of Patients With Prostate CancerProstate CancerNCT05690399Assiut University100